Earnings Call Excerpt
Datascope Corp. (DSCP)
F4Q08 (Qtr End 06/30/08) Earnings Call Transcript
August 12, 2008 12:00 pm ET
Executives
Hank Scaramelli – VP and CFO
Larry Saper - Chairman and CEO
Nino Laudani – VP and COO
Analysts
Greg Brash – Sidoti & Company
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Datascope Corp. fourth quarter earnings release conference call. Today's call is being recorded. At this time, all lines have been placed in a listen only mode and the floor will be open for question and comments following the presentation. The comments that we will make this afternoon will include forward-looking statements but are intended to fall within the Safe Harbor provision of the Securities Litigation Reform Act. Actual results may differ from these forward-looking statements due to various risks and uncertainties including those that are disclosed in our press release and regular filings with the SEC.
This conference call is being webcast live over the Internet. A replay of the call will also be available on the Investor Relations page of our website for 10 days. At this time, it is my pleasure to turn the floor over to Mr. Hank Scaramelli, Chief Financial Officer, please go ahead.
Hank Scaramelli
Good afternoon, everyone. Welcome to Datascope's conference call to review the results for the fourth quarter of fiscal 2008. I am Hank Scaramelli, CFO of the company. Joining me in the call is Larry Saper, Chairman and CEO of Datascope; and Dr. Antonino Laudani, Datascope's Chief Operating Officer.
First we will have some comments primary then I will give a brief financial review. Dr. Laudani will comment on the operation of the ongoing businesses. Larry?
Larry Saper
Thanks, Hank. We had a very, very good quarter but today, I'm going to let Hank and Nino a review of the quarter. I just have a – I'll be available later for question. I have just one comment that look at Q3 and Q4. They tell the story of the company's new momentum, because for the first time now, we exclude everything except the continuing business. What I mean, back in May, we had the sale of the patient monitoring assets and just last week we announced the sale of the remaining asset that now are excluded by the continuing business. Those assets will be – the performance of these assets, which were in decline, affected Q3. Now, when you look at Q3 and Q4, they tell the story of our new momentum.
- To read the full transcript on Seeking Alpha, click here »
